The 62 rating InvestorsObserver gives to Capricor Therapeutics Inc (CAPR) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 74 percent of stocks in the Biotechnology industry, CAPR’s 62 overall rating means the stock scores better than 62 percent of all stocks.
CAPR has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on CAPR!